Pharma's Almanac

94 Articles Available

4 4

Capacity Issues and the Question: To Insource or Outsource?

LSL-M08-12-NI-001

CROs & CMOs: Focusing On Innovation

LSL-M05-12-NI-001

Biotherapeutics Outpace Conventional Therapies

BIO-M03-12-NI-001

Outsourcing Trends for 2012 — Top Services by Customer Segment and the Prevalence of Contracting to Emerging Markets

GXP-M02-12-NI-001

Key Drivers for Outsourcing Partner Selection

LSL-M02-12-NI-001

Best Practices for Targeted Marketing Communications

DDD-M01-12-NI-001

Using Industry Spending Data to Develop Strategic Marketing

PQO-M01-12-NI-001

Spending Trends in the CMO and CRO Market

PPO-M01-12-NI-001

Who Should Be Doing Your Pharmaceutical Analytical Testing — a CRO or CMO?

PPO-M12-11-NI-001

Overcoming Barriers to Forming Successful Relationships with CMOs in Emerging Markets

PQO-M12-11-NI-001

Why Sponsors Should Regularly Re-evaluate their Preferred Vendor List of Contract Research and Contract Manufacturing Organizations

LSL-M12-11-NI-001

Is a CMO With a Global Supply Chain Always the Best Option?

LSL-M11-11-NI-001

What CROs and CMOs Can Learn from Q3 Outsourcing Data and 2011 Trends

PQO-M11-11-NI-001

Tools That Improve Outsourcing Selection

PPO-M11-11-NI-001

Sterile Manufacturing Opportunities

PPO-M10-11-NI-001

Contract Services Spending: Who's Spending What, and Where?

BIO-M10-11-NI-001

Connecting CMOs and CROs and Big Pharma

PPO-M09-11-NI-001

Do Companies That Offer Regulatory Support Services Score Higher On Regulatory Compliance?

LSL-M08-11-NI-001

Nice Insight Announces Publication Of Its Q2 CRO/CMO Quarterly Intelligence Report

ACT-M06-11-NI-001

Strong Regulatory Compliance and Reliability Indicative of Solid Partnership Choices

LSL-M06-11-NI-001

The Conversation That Got Me Thinking Of A New Business Concept

Bringing Order To The Outsourced Manufacturing Space

PC0-M04-11-NI-001

4 4

CMO (4)